Search research articles
Contact Us
Filters
Showing results (71-80 of 112) with videos related to
Page
of 12
Sort By:
Journal of Cancer Research and Clinical Oncology
|
July 20, 2021
Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinoma
Vera Himmelsbach, Mate Knabe, Phillip G Ferstl, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 16, 2014
Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging
Waralee Watcharin, Christian Schmithals, Thomas Pleli, et al.
Scientific Reports
|
October 2, 2020
Tax1BP1 limits hepatic inflammation and reduces experimental hepatocarcinogenesis
Oliver Waidmann, Thomas Pleli, Andreas Weigert, et al.
Journal of Gastroenterology and Hepatology
|
August 3, 2018
Risk factors for early and late procedure-related adverse events in percutaneous endoscopic gastrostomy: A single center, retrospective study
Jan Peveling-Oberhag, Imad Osman, Dirk Walter, et al.
Hepatology Communications
|
January 13, 2021
Point Shear-Wave Elastography Using Acoustic Radiation Force Impulse Imaging for the Prediction of Liver-Related Events in Patients With Chronic Viral Hepatitis
Lisa Hernandez Sampere, Johannes Vermehren, Victoria T Mücke, et al.
Frontiers in Microbiology
|
December 9, 2021
Molecular Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Liver Transplant Candidates
Tilman G Schultze, Philip G Ferstl, David Villinger, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
May 22, 2022
Comparison of short-course antibiotic therapy of 6 or less days with a longer treatment in patients with cholangitis after liver transplantation
Philip G Ferstl, Alexander Queck, Katharina Bremer, et al.
JHEP Reports : Innovation in Hepatology
|
February 18, 2026
Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinoma
Jan Henrik Klug, Blerina Aliraj, Lucia Alcober-Boquet, et al.
Neoplasia (New York, N.Y.)
|
June 30, 2012
Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels
Jörg Haupenthal, Verena Bihrer, Huedayi Korkusuz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 8, 2017
Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition
Ahmed Atef Ibrahim, Christian Schmithals, Erik Kowarz, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 112) with videos related to
Sort By:
Page
of 12
Journal of Cancer Research and Clinical Oncology
|
July 20, 2021
Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinoma
Vera Himmelsbach, Mate Knabe, Phillip G Ferstl, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 16, 2014
Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging
Waralee Watcharin, Christian Schmithals, Thomas Pleli, et al.
Scientific Reports
|
October 2, 2020
Tax1BP1 limits hepatic inflammation and reduces experimental hepatocarcinogenesis
Oliver Waidmann, Thomas Pleli, Andreas Weigert, et al.
Journal of Gastroenterology and Hepatology
|
August 3, 2018
Risk factors for early and late procedure-related adverse events in percutaneous endoscopic gastrostomy: A single center, retrospective study
Jan Peveling-Oberhag, Imad Osman, Dirk Walter, et al.
Hepatology Communications
|
January 13, 2021
Point Shear-Wave Elastography Using Acoustic Radiation Force Impulse Imaging for the Prediction of Liver-Related Events in Patients With Chronic Viral Hepatitis
Lisa Hernandez Sampere, Johannes Vermehren, Victoria T Mücke, et al.
Frontiers in Microbiology
|
December 9, 2021
Molecular Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Liver Transplant Candidates
Tilman G Schultze, Philip G Ferstl, David Villinger, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
May 22, 2022
Comparison of short-course antibiotic therapy of 6 or less days with a longer treatment in patients with cholangitis after liver transplantation
Philip G Ferstl, Alexander Queck, Katharina Bremer, et al.
JHEP Reports : Innovation in Hepatology
|
February 18, 2026
Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinoma
Jan Henrik Klug, Blerina Aliraj, Lucia Alcober-Boquet, et al.
Neoplasia (New York, N.Y.)
|
June 30, 2012
Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels
Jörg Haupenthal, Verena Bihrer, Huedayi Korkusuz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 8, 2017
Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition
Ahmed Atef Ibrahim, Christian Schmithals, Erik Kowarz, et al.
Page
of 12